July 25, 2022
Dhondt B et al. World Journal of Urology 2018
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time
You might also be interested by
Posters
Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?
April 27, 2025
More infoCase Studies & Whitepapers
Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology
April 21, 2025
More info